Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Cancer Patients

0
21
Investigators examined the role of the CD137+ T cells in the improvement of patients’ selection for immunotherapy treatment.
[Clinical Cancer Research]
Abstract